Cheap antidepressant shows promise against COVID-19
Fluvoxamine, an inexpensive antidepressant, might help keep patients with COVID-19 from developing severe disease, according to a new study published in The Lancet Global Health on Wednesday. Researchers in Brazil recruited nearly 1,500 COVID-19 patients at high risk for complications
The journal Nature Communications published a study on Friday that claims the level of IgG antibodies against SARS-CoV-2 stays stable, or even increases, as long as seven months into infection. Researchers also say that antibodies against the common-cold can also protect from COVID-19. The objective
Genes2Me, a leading Genetic diagnostics and research Company, launched its high throughput RT PCR testing lab for COVID-19 and other Infectious diseases at Gurgaon with a current capacity of testing 15K samples a day.
The fully automated high throughput lab is NABL accredited and ICMR approved,
Breakthrough cases and COVID-19 recovered individuals with one or two doses of vaccine have relatively higher protection against Delta variant in comparison to those administered either one or two doses of Covishield, a study stated.
Prior vaccination results in less severe disease against subsequent infection provide
The SARS-CoV-2 sero-positivity rate among children is high and comparable to the adult population and hence, it is unlikely that any future third wave of the prevailing COVID-19 variant would disproportionately affect children aged two years and above, according to the interim findings of an
Bharat Biotech hereby communicates the following message regarding pricing of COVAXIN® for Central Government, State Governments, and Private Hospitals, we believe it is pertinent to place facts on record for the Media and the public at large, so that they can understand and appreciate our
The B.1.617.1 and B.1.617.2 variants of the COVID-19, first identified in India, have been named as ‘Kappa’ and ‘Delta’ respectively, the World Health Organisation (WHO) announced on Monday as it named various variants of the coronavirus using Greek alphabets.
“Today, @WHO announces new, easy-to-say labels for